IFRX logoIFRX
InflaRx N.V.

10,257
Loading...
Loading...
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
74

Frequently Asked Questions

What is Market Cap of InflaRx N.V.?
What is the 52-week high for InflaRx N.V.?
What is the 52-week low for InflaRx N.V.?
What is InflaRx N.V. stock price today?
What was InflaRx N.V. stock price yesterday?
What is the PE ratio of InflaRx N.V.?
What is the Price-to-Book ratio of InflaRx N.V.?
What is the 50-day moving average of InflaRx N.V.?
How many employess does InflaRx N.V. has?

Latest IFRX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.